Meritech Capital is a venture capital firm that focuses on late-stage investments in market-leading technology companies, aiming to help them become enduring brands. Their strategy involves providing assistance beyond just capital, often integrating as team members with a disciplined approach to support growth and enhance operations.
Portfolio
25
Fund Size
$4.1B
Top Stage
Growth
Last 12 Mo
7
Team
BM
Brian McLoughlin
Managing Partner
PM
Paul Madera
Partner
AC
Alex Clayton
Investment Team
Stage Distribution
Portfolio
25 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Filevine | Growth | $400M | Sep 2025 |
| inforcer | Series B | $29.8M | Jul 2025 |
| Talon.One | Growth | $135M | Jul 2025 |
| Owner.com | Growth | $120M | May 2025 |
| Astronomer | Series D | $93M | May 2025 |
| True Anomaly, Inc. | Series C | $260M | Apr 2025 |
| Pennylane | Growth | $75M | Apr 2025 |
| Augment | Growth | $252M | Apr 2024 |
| Pigment | Series B | $65M | Sep 2022 |
| DataStax | Growth | $115M | Jun 2022 |
| Self Financial | Series E | $50M | Sep 2021 |
| xentral | Series B | $75M | Aug 2021 |
| Extend | Series C | $260M | May 2021 |
| Newfront | Series C | — | Oct 2020 |
| Extend | Series B | $40M | Oct 2020 |
| Icertis | Series E | $115M | Jul 2019 |
| Verkada | Series B | $40M | Apr 2019 |
| 10x Genomics | Series D | $35M | Jan 2019 |
| Snowflake | Growth | $450M | Oct 2018 |
| Snowflake Computing | Growth | $450M | Oct 2018 |
| Anaplan | Series F | $60M | Dec 2017 |
| Lyra Health | Series D | $110M | — |
| ForgeRock | Series E | $93.5M | — |
| Pendulum Therapeutics | Series D | $126M | — |
| Augment Code | Unknown | — | — |
Top Co-Investors
Sequoia Capital6 shared
Sutter Hill Ventures4 shared
Accel3 shared
Insight Partners2 shared
Salesforce2 shared
Altimeter Capital2 shared
Capital One Ventures2 shared
Madrona Venture Group2 shared
Redpoint Ventures2 shared
Iconiq Capital2 shared
Wing2 shared
Index Ventures2 shared
Lightspeed Venture Partners2 shared
Innovation Endeavors2 shared
Addition1 shared
Adams Street1 shared
Casdin Capital1 shared
Glynn Capital1 shared
Greylock Partners1 shared
Last updated: 1 March 2026